BANK OF AMERICA CORP /DE/ - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$1,282,800
+44.8%
235,376
+78.3%
0.00%
Q2 2023$885,882
-77.5%
132,024
-70.3%
0.00%
Q1 2023$3,930,895
+264.1%
445,175
+215.0%
0.00%
Q4 2022$1,079,716
-9.4%
141,324
-15.6%
0.00%
Q3 2022$1,192,000
-13.7%
167,377
-1.9%
0.00%
Q2 2022$1,381,000
-52.5%
170,675
-18.5%
0.00%
Q1 2022$2,908,000
-55.5%
209,475
-10.1%
0.00%
-100.0%
Q4 2021$6,534,000
+2.1%
232,888
+23.7%
0.00%0.0%
Q3 2021$6,398,000
-20.5%
188,248
-4.4%
0.00%0.0%
Q2 2021$8,050,000
+37.9%
197,001
+35.9%
0.00%0.0%
Q1 2021$5,836,000
-34.5%
144,971
-3.8%
0.00%0.0%
Q4 2020$8,914,000
+13.6%
150,749
-6.6%
0.00%0.0%
Q3 2020$7,847,000
-8.2%
161,380
-8.7%
0.00%0.0%
Q2 2020$8,552,000
+129.7%
176,793
+31.9%
0.00%0.0%
Q1 2020$3,723,000
-34.0%
134,002
-28.9%
0.00%0.0%
Q4 2019$5,638,000
+666.0%
188,431
+690.1%
0.00%
Q3 2019$736,00023,8490.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders